Q2 2019
The company increased its overall year-over-year revenue by 5% in Q2.
Revenue, membership and total visits each saw substantial growth since last year's Q2 earnings, although the company is still chasing profitability.
News from CMS, UnitedHealthGroup, Livongo and others.
The company's executives lauded the CGM system, which saw a 72.9% increase in organic sales during the last quarter, and hinted at implementations of the tech beyond diabetes alone.
Mercom Capital Group's latest numbers also suggest that upcoming IPOs could cast a long shadow on the direction of digital health investing.
Pharma companies also continued to explore the promises of digital therapeutics.